Breaking News, Collaborations & Alliances

BASF, Bend Research in Solubility Pact

Aims to develop excipients to enhance solubility, bioavailability

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BASF and Bend Research have signed an agreement to evaluate and develop excipients to enhance the solubility and bioavailability of poorly soluble drugs. The collaboration aims to meet increasing challenges of poorly soluble APIs (BCS Class II and IV compounds). The initial focus will be on optimizing new vinylpyrrolidone based copolymers being developed for the solubilization of poorly soluble APIs.   BASF will provide its expertise in ingredient formulation and material science and its excipie...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters